| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 660948 | 69793 | PRAVASTATINA TECNIGEN 40 mg COMPRIMIDOS EFG | PRAVASTATINA TECNIGEN 40 mg COMPRIMIDOS EFG , 28 comprimidos | 40 mg | 6 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69793/69793_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69793/69793_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 12947 | TECNIMEDE ESPAÑA INDUSTRIA FARMACEUTICA S.A. | 2008-05-06 | 1 | 1 | 1 | 2008-05-06 | 2008-05-06 | 1 | 2011-06-15 | View Edit Delete | ||||||||||||
| 660752 | 01172006 | KALETRA 100 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | KALETRA 100 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 60 comprimidos | 100 mg/25 mg | 6 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01172006/01172006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01172006/01172006_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | ABBVIE SPAIN, S.L.U. | 2008-04-24 | 1 | 1 | 1 | 2008-04-24 | 2008-04-24 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 661058 | 62038 | PRED FORTE 10 MG/ML COLIRIO EN SUSPENSION | PRED FORTE 10 MG/ML COLIRIO EN SUSPENSION , 1 frasco de 5 ml | 10 mg/ml | 6 | 5 | 26 | 1 frasco de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62038/62038_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62038/62038_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16052 | ABBVIE SPAIN, S.L.U. | 1999-03-01 | 1 | 1 | 1 | 1999-03-01 | 1999-03-01 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 661428 | 70040 | EFETAMOL 100 mg/ml SOLUCION ORAL | EFETAMOL 100 mg/ml SOLUCION ORAL, 1 frasco de 60 ml | 100 mg/ml | 6 | 60 | 26 | 1 frasco de 60 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70040/70040_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70040/70040_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1473 | ITALFARMACO S.A. | 2008-08-26 | 1 | 1 | 1 | 2008-08-26 | 2008-08-26 | 1 | 2012-07-02 | View Edit Delete | ||||||||||||
| 661008 | 69828 | RENOCIS 1 mg EQUIPO DE REACTIVOS PARA PREPARACION RADIOFARMACEUTICA | RENOCIS 1 mg EQUIPO DE REACTIVOS PARA PREPARACION RADIOFARMACEUTICA, 5 viales | 1 mg | 6 | 5 | 34 | 5 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69828/69828_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69828/69828_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 689 | CURIUM PHARMA SPAIN S.A. | 2008-05-26 | 1 | 1 | 1 | 2008-05-26 | 2008-05-26 | 0 | 2012-01-09 | View Edit Delete | ||||||||||||
| 661397 | 62015 | TIONER 100 MG/ML SOLUCION ORAL | TIONER 100 MG/ML SOLUCION ORAL , 1 frasco de 30 ml | 100 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62015/62015_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62015/62015_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13469 | ARISTO PHARMA IBERIA S.L. | 1998-12-01 | 1 | 1 | 1 | 1998-12-01 | 1998-12-01 | 1 | 2011-10-10 | View Edit Delete | ||||||||||||
| 660432 | 69553 | RISPERIDONA VIATRIS 1 MG/ML SOLUCION ORAL EFG | RISPERIDONA VIATRIS 1 MG/ML SOLUCION ORAL EFG, 1 frasco de 100 ml | 1 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69553/69553_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69553/69553_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | VIATRIS PHARMACEUTICALS S.L.U. | 2008-01-28 | 1 | 1 | 1 | 2008-01-28 | 2008-01-28 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660331 | 69514 | RISPERIDONA TEVA 1 mg/ml SOLUCION ORAL EFG | RISPERIDONA TEVA 1 mg/ml SOLUCION ORAL EFG, 1 frasco de 100 ml | 1 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69514/69514_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69514/69514_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-12-28 | 1 | 1 | 1 | 2007-12-28 | 2007-12-28 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660653 | 69669 | CABERGOLINA TEVA 0,5 mg COMPRIMIDOS EFG | CABERGOLINA TEVA 0,5 mg COMPRIMIDOS EFG , 2 comprimidos | 0,5 mg | 6 | 2 | 10 | 2 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69669/69669_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69669/69669_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2008-03-18 | 1 | 1 | 1 | 2008-03-18 | 2008-03-18 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660655 | 69669 | CABERGOLINA TEVA 0,5 mg COMPRIMIDOS EFG | CABERGOLINA TEVA 0,5 mg COMPRIMIDOS EFG , 8 comprimidos | 0,5 mg | 6 | 8 | 10 | 8 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69669/69669_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69669/69669_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2008-03-18 | 1 | 1 | 1 | 2008-03-18 | 2008-03-18 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660713 | 69686 | CABERGOLINA TEVA 2 mg COMPRIMIDOS EFG | CABERGOLINA TEVA 2 mg COMPRIMIDOS EFG , 20 comprimidos | 2 mg | 6 | 20 | 10 | 20 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69686/69686_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69686/69686_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2008-03-18 | 1 | 1 | 1 | 2008-03-18 | 2008-03-18 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660714 | 69687 | CABERGOLINA TEVA 1 mg COMPRIMIDOS EFG | CABERGOLINA TEVA 1 mg COMPRIMIDOS EFG , 20 comprimidos | 1 mg | 6 | 20 | 10 | 20 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69687/69687_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69687/69687_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2008-03-18 | 1 | 1 | 1 | 2008-03-18 | 2008-03-18 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 661621 | 69516 | AZITROMICINA TEVA 200 mg/5ml POLVO PARA SUSPENSIÓN ORAL EFG | AZITROMICINA TEVA 200 mg/5ml POLVO PARA SUSPENSIÓN ORAL EFG , 1 frasco de 30 ml | 200 mg/5 ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69516/69516_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69516/69516_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2008-01-10 | 1 | 1 | 1 | 2008-01-10 | 2008-01-10 | 1 | 2011-10-24 | 660337 | View Edit Delete | |||||||||||
| 661466 | 52373 | AMOXICILINA ARDINE 125 mg/5 ml POLVO PARA SUSPENSION ORAL EFG | AMOXICILINA ARDINE 125 mg/5 ml POLVO PARA SUSPENSION ORAL EFG, 1 frasco de 120 ml | 125 mg/5 ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/52373/52373_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/52373/52373_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 1974-05-01 | 1 | 1 | 1 | 1974-05-01 | 2008-09-26 | 1 | 2011-02-08 | 711028 | View Edit Delete | |||||||||||
| 661467 | 53626 | AMOXICILINA ARDINE 250 mg/5 ml POLVO PARA SUSPENSION ORAL EFG | AMOXICILINA ARDINE 250 mg/5 ml POLVO PARA SUSPENSION ORAL EFG , 1 frasco de 120 ml | 250 mg/5 ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/53626/53626_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/53626/53626_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 1976-02-01 | 1 | 1 | 1 | 1976-02-01 | 2008-09-26 | 1 | 2011-02-08 | 939314 | View Edit Delete | |||||||||||
| 661331 | 69988 | CONCERTA 27 mg COMPRIMIDOS DE LIBERACION PROLONGADA | CONCERTA 27 mg COMPRIMIDOS DE LIBERACION PROLONGADA, 30 comprimidos | 27 mg | 6 | 30 | 10 | 30 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69988/69988_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69988/69988_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71027 | JANSSEN CILAG S.A. | 2008-07-23 | 1 | 1 | 1 | 2008-07-23 | 2008-07-23 | 1 | 2016-10-26 | Lista II | View Edit Delete | |||||||||||
| 660559 | 67635 | GLUCOSA B.BRAUN 70% SOLUCIÓN PARA PERFUSIÓN | GLUCOSA B.BRAUN 70% SOLUCIÓN PARA PERFUSIÓN , 10 frascos 500 ml | 70% | 6 | 10 | 48 | 10 frascos 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67635/67635_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67635/67635_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 306 | B BRAUN MEDICAL S.A. | 2006-03-21 | 1 | 1 | 1 | 2006-03-21 | 2008-02-18 | 0 | 2011-06-20 | View Edit Delete | ||||||||||||
| 660782 | 69726 | DALSY 40 mg/ml SUSPENSION ORAL | DALSY 40 mg/ml SUSPENSION ORAL , 1 frasco de 150 ml | 40 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69726/69726_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69726/69726_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L. | 2008-04-07 | 1 | 1 | 1 | 2008-04-07 | 2008-04-07 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 661250 | 61109 | CRISTALMINA 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA | CRISTALMINA 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA, 1 frasco de 25 ml | 10 mg/ml | 6 | 25 | 26 | 1 frasco de 25 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61109/61109_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61109/61109_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | LABORATORIOS SALVAT S.A. | 1996-04-01 | 1 | 1 | 1 | 1996-04-01 | 2008-07-09 | 1 | 2011-07-04 | View Edit Delete | ||||||||||||
| 661057 | 03260021 | STALEVO 200 mg/50 mg/200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | STALEVO 200 mg/50 mg/200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 100 comprimidos | 200 mg/50 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03260021/03260021_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03260021/03260021_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42344 | ORION PHARMA S.L. | 2008-06-10 | 1 | 1 | 1 | 2008-06-10 | 2008-06-10 | 1 | 2012-01-02 | View Edit Delete |
Page 171 of 1036, showing 20 records out of 20709 total, starting on record 3401, ending on 3420